This Overlooked Warren Buffett Stock Is Absurdly Cheap Right Now

Constellation Brands reported a sharper sales decline, with wine and spirits net sales down 51% and beer revenue down 3%, but net income swung to nearly $1.7 billion from an $81 million loss as a $2.8 billion impairment rolled off. The company raised its dividend to $4.12 per share annually, maintained a 2.5% yield, and completed a $924 million buyback, while guiding for flat sales growth at the midpoint in fiscal 2027. The stock trades at 17x earnings versus 29x for the S&P 500, supporting the case for a contrarian recovery thesis.

Analysis

The market is beginning to treat STZ less like a growth story and more like a capital-allocation vehicle with a defensible cash engine. That matters because when a consumer staples-adjacent company can still cover a rising payout and repurchase stock while volumes soften, the equity can re-rate on yield support alone even before top-line inflects. The second-order effect is that management has effectively shortened the earnings cycle: instead of waiting for category growth, it can keep per-share value moving through buybacks, margin discipline, and mix shifts toward higher-velocity brands.

The real competitive issue is not whether alcohol disappears, but who owns the shelf space and tap handle share as aggregate demand fragments. If younger consumers are less loyal to legacy wine and spirits, the winners are the brands with the strongest retailer leverage, on-premise visibility, and import cachet; that favors STZ's beer franchise relative to smaller domestic labels and weaker wine portfolios. The divestiture cleanup also reduces complexity, which can improve ROIC and make the company easier to underwrite in a slow-growth regime.

The key risk is that the current narrative may be too dependent on stabilization in beer rather than a true turn in end-market demand. A flat sales guide is acceptable for now, but if the beer base keeps contracting even low single digits, the valuation thesis shifts from "cheap compounder" to "value trap with a dividend." The biggest catalyst over the next 3-9 months is evidence that the new CEO can sustain margin and cash conversion without sacrificing share; absent that, the stock may stall despite the headline-friendly capital returns.

Contrarianly, the consensus may be underestimating how powerful a 2.5% dividend plus buyback support can be in a market starved for defensiveness with visible cash flow. The more interesting trade is not simply long STZ on a cheap P/E, but long STZ versus other consumer discretionary names whose earnings are more cyclical and whose capital returns are less secure. If operating results merely stop deteriorating, the stock can outperform on multiple expansion alone.

Key Decisions for Investors

• Go long STZ for a 3-6 month trade with a stop if beer revenue re-accelerates down; target is a modest multiple re-rate toward low-20s P/E if cash flow and dividend coverage remain intact.
• Pair trade: long STZ / short a weaker consumer discretionary basket over the next 1-2 quarters to express the view that cash-return support matters more than growth scarcity in a slowing demand tape.
• Sell downside protection on STZ only if shares retrace into weakness; preferred structure is a 3-6 month cash-secured put near the recent support zone to monetize elevated implied volatility while defining entry.
• Avoid chasing the name after sharp rallies; use any post-earnings pullback to build exposure, since the thesis depends on steady execution rather than a near-term demand inflection.
• Monitor for confirmation that the new CEO can preserve margins; if gross profit trends stabilize for two consecutive quarters, add to the long as that would likely unlock further buyback-led support.